0001209191-23-053508.txt : 20231024
0001209191-23-053508.hdr.sgml : 20231024
20231024194207
ACCESSION NUMBER: 0001209191-23-053508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231023
FILED AS OF DATE: 20231024
DATE AS OF CHANGE: 20231024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Janhofer Guenter
CENTRAL INDEX KEY: 0001991537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 231343681
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-23
0
0001662774
Quince Therapeutics, Inc.
QNCX
0001991537
Janhofer Guenter
C/O QUINCE THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 1250
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
0
Employee Stock Option (right to buy)
0.99
2023-10-23
4
A
0
300000
0.00
A
2033-10-22
Common Stock
300000
300000
D
Twenty-five percent of the shares subject to the stock option vests on the first anniversary of the grant date of October 23, 2023, and the remainder vests in 36 equal monthly installments thereafter for the following three years, subject to the Reporting Person's continuous service as the officer of the Issuer as of each such date.
/s/ Brendan Hannah, Attorney-in-Fact for Guenter Janhofer, M.D., Ph.D.
2023-10-24